Document
IPR2017-01995, No. 2076 Exhibit - Ex 2076 Mylan Judgment (P.T.A.B. Feb. 8, 2019)
Cite Document
IPR2017-01995, No. 2076 Exhibit - Ex 2076 Mylan Judgment (P.T.A.B. Feb. 8, 2019)
+ More Snippets
Document
IPR2017-01995, No. 1051 Exhibit - Sale Order (P.T.A.B. Jan. 4, 2019)
Cite Document
IPR2017-01995, No. 1051 Exhibit - Sale Order (P.T.A.B. Jan. 4, 2019)
+ More Snippets
Document
IPR2017-01995, No. 2074 Exhibit - Ex 2074 Opening Brief (P.T.A.B. Feb. 8, 2019)
Cite Document
IPR2017-01995, No. 2074 Exhibit - Ex 2074 Opening Brief (P.T.A.B. Feb. 8, 2019)
+ More Snippets
Document
IPR2017-01995, No. 3002 Exhibit - Ex 3002 (P.T.A.B. Aug. 31, 2018)
Cite Document
IPR2017-01995, No. 3002 Exhibit - Ex 3002 (P.T.A.B. Aug. 31, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2007 Exhibit - Exhibit 2007 (P.T.A.B. Dec. 12, 2017)
Cite Document
IPR2017-01995, No. 2007 Exhibit - Exhibit 2007 (P.T.A.B. Dec. 12, 2017)
+ More Snippets
Document
IPR2017-01995, No. 2049 Exhibit - N Hudson et al, Famotidine for healing and maintenance in nonsteroidal anti inflammatory drug associated gastroduodenal ulceration, Gastroenterology, 1121...
Cite Document
IPR2017-01995, No. 2049 Exhibit - N Hudson et al, Famotidine for healing and maintenance in nonsteroidal anti inflammatory drug associated gastroduodenal ulceration, Gastroenterology, 1121817 1822 199
+ More Snippets
Document
IPR2017-01995, No. 2067-2 Exhibit - AstraZenecaPozen Collaboration and License Agreement August 1, 2006 PROTECTIVE ORDER MATERIAL (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2067-2 Exhibit - AstraZenecaPozen Collaboration and License Agreement August 1, 2006 PROTECTIVE ORDER MATERIAL (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2041 Exhibit - VIMOVO Prescribing Information (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2041 Exhibit - VIMOVO Prescribing Information (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2035 Exhibit - Hartmann et al, Twenty four hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor p...
Cite Document
IPR2017-01995, No. 2035 Exhibit - Hartmann et al, Twenty four hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantopra
+ More Snippets
Document
IPR2017-01995, No. 2068 Exhibit - IPR2017 01995 Corrected Declaration of Bryan D Beel in Support of Petitioner¿¿¿s Evidence, June 1, 2018 (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2068 Exhibit - IPR2017 01995 Corrected Declaration of Bryan D Beel in Support of Petitioner¿¿¿s Evidence, June 1, 2018 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2054 Exhibit - H Koop, Review article metabolic consequences of long term inhibition of acid secretion by omeprazole, Aliment Pharmacol Ther 6399¿¿¿406 1992 (P.T.A.B. Ju...
Cite Document
IPR2017-01995, No. 2054 Exhibit - H Koop, Review article metabolic consequences of long term inhibition of acid secretion by omeprazole, Aliment Pharmacol Ther 6399¿¿¿406 1992 (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2057 Exhibit - Nexium label (P.T.A.B. Jun. 1, 2018)
Cite Document
IPR2017-01995, No. 2057 Exhibit - Nexium label (P.T.A.B. Jun. 1, 2018)
+ More Snippets
Document
IPR2017-01995, No. 1047 Exhibit - Stipulation and Order (P.T.A.B. Jan. 25, 2018)
Cite Document
IPR2017-01995, No. 1047 Exhibit - Stipulation and Order (P.T.A.B. Jan. 25, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2009 Exhibit - Declaration of Susan Krumplitsch in Support of Motion to Appear Pro Hac Vice on Behalf of Patent Owner Horizon Pharma USA, Inc (P.T.A.B. Jan. 12, 2018)
Cite Document
IPR2017-01995, No. 2009 Exhibit - Declaration of Susan Krumplitsch in Support of Motion to Appear Pro Hac Vice on Behalf of Patent Owner Horizon Pharma USA, Inc (P.T.A.B. Jan. 12, 2018)
+ More Snippets
Document
IPR2017-01995, No. 2055 Exhibit - Donnellan C, Preston C, Moayyedi P, Sharma N, Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseas...
Cite Document
IPR2017-01995, No. 2055 Exhibit - Donnellan C, Preston C, Moayyedi P, Sharma N, Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease Review, The
+ More Snippets